Leiden, March 3, 2023 – MIMETAS has achieved major milestones in its partnership with Roche, developing models for Inflammatory Bowel Disease (IBD) and Hepatitis B Virus infections (HBV).
In July 2021, MIMETAS and Roche entered a risk-sharing collaboration to develop human disease models for the characterization of novel compounds in Inflammatory Bowel Disease (IBD) and Hepatitis B virus infections (HBV). You can find the original press release here.
Image: https://www.mimetas.com
{iframe}https://www.mimetas.com/en/news/640/mimetas-achieves-important-milestones-in-partnership-with-roche.html{/iframe}